semaglutide alexandria la Alexandria, LA
Description
5.2 Potential Risks and Contraindications While Semaglutide has demonstrated efficacy in improving glycemic control, promoting weight loss, and reducing cardiovascular risk factors in individuals with type 2 diabetes and obesity, certain populations may be at increased risk of adverse events or may have contraindications to Semaglutide therapy
Coverage for preventive or longevity use is less common
For a 200-pound individual, that is 2 to 4 pounds
They are FDA-approved for managing type 2 diabetes and have been found effective in promoting weight loss in clinical trials
